575 related articles for article (PubMed ID: 24106929)
1. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
4. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
5. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
6. The effect of high-fat diet and inhibition of ceramide production on insulin action in liver.
Zabielski P; Daniluk J; Hady HR; Markowski AR; Imierska M; Górski J; Blachnio-Zabielska AU
J Cell Physiol; 2019 Feb; 234(2):1851-1861. PubMed ID: 30067865
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
9. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
10. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Safwat GM; Pisanò S; D'Amore E; Borioni G; Napolitano M; Kamal AA; Ballanti P; Botham KM; Bravo E
Nutrition; 2009; 25(11-12):1157-68. PubMed ID: 19592219
[TBL] [Abstract][Full Text] [Related]
11. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
12. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
[TBL] [Abstract][Full Text] [Related]
13. Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2012 Feb; 77(2):180-6. PubMed ID: 22348478
[TBL] [Abstract][Full Text] [Related]
14. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
Kasumov T; Li L; Li M; Gulshan K; Kirwan JP; Liu X; Previs S; Willard B; Smith JD; McCullough A
PLoS One; 2015; 10(5):e0126910. PubMed ID: 25993337
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease.
Jiang M; Li C; Liu Q; Wang A; Lei M
Front Endocrinol (Lausanne); 2019; 10():665. PubMed ID: 31616384
[TBL] [Abstract][Full Text] [Related]
16. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Wiesiołek-Kurek P; Piotrowska DM; Łukaszuk B; Chabowski A; Żendzianendzian-Piotrowska M
Biomed Res Int; 2014; 2014():980815. PubMed ID: 24701589
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.
Tong M; Longato L; Ramirez T; Zabala V; Wands JR; de la Monte SM
Int J Exp Pathol; 2014 Feb; 95(1):49-63. PubMed ID: 24456332
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]